AAAAAA

   
Results: 1-24 |
Results: 24
THE RISK OF NEPHRECTOMY DURING LOCAL-CONTROL IN ABDOMINAL NEUROBLASTOMA
Authors: SHAMBERGER RC SMITH EI JOSHI VV RAO PV HAYES FA BOWMAN LC CASTLEBERRY RP
Citation: Rc. Shamberger et al., THE RISK OF NEPHRECTOMY DURING LOCAL-CONTROL IN ABDOMINAL NEUROBLASTOMA, Journal of pediatric surgery, 33(2), 1998, pp. 161-164
GENETIC STAGING OF UNRESECTABLE OR METASTATIC NEUROBLASTOMA IN INFANTS - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: BOWMAN LC CASTLEBERRY RP CANTOR A JOSHI V COHN SL SMITH EI YU A BRODEUR GM HAYES FA LOOK AT
Citation: Lc. Bowman et al., GENETIC STAGING OF UNRESECTABLE OR METASTATIC NEUROBLASTOMA IN INFANTS - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of the National Cancer Institute, 89(5), 1997, pp. 373-380
PILOT-STUDY OF ADJUNCTIVE GM-CSF (YEAST-DERIVED) FOR FLUCONAZOLE-RESISTANT ORAL CANDIDIASIS IN HIV-1 INFECTION
Authors: SWINDELLS S KLEINSCHMIDT DR HAYES FA
Citation: S. Swindells et al., PILOT-STUDY OF ADJUNCTIVE GM-CSF (YEAST-DERIVED) FOR FLUCONAZOLE-RESISTANT ORAL CANDIDIASIS IN HIV-1 INFECTION, Infectious diseases in clinical practice, 6(4), 1997, pp. 278-279
A PILOT-STUDY IN THE USE OF GM-CSF IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTED INDIVIDUALS
Authors: BERNSTEIN ZP BROOKS S HAYES FA GOULD M JACOB S TOMASI TB
Citation: Zp. Bernstein et al., A PILOT-STUDY IN THE USE OF GM-CSF IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTED INDIVIDUALS, Blood, 90(10), 1997, pp. 584-584
SAFETY OF FLT3 LIGAND IN HEALTHY-VOLUNTEERS
Authors: LEBSACK ME MCKENNA HJ HOEK JA HANNA R FENG A MARASHOVSKY E HAYES FA
Citation: Me. Lebsack et al., SAFETY OF FLT3 LIGAND IN HEALTHY-VOLUNTEERS, Blood, 90(10), 1997, pp. 751-751
RANDOMIZED DOUBLE-BLIND PROSPECTIVE TRIAL TO EVALUATE THE EFFECTS OF SARGRAMOSTIM VERSUS PLACEBO IN A MODERATE-DOSE FLUOROURACIL, DOXORUBICIN, AND CYCLOPHOSPHAMIDE ADJUVANT CHEMOTHERAPY PROGRAM FOR STAGE-II AND STAGE-III BREAST-CANCER
Authors: JONES SE SCHOTTSTAEDT MW DUNCAN LA KIRBY RL GOOD RH MENNEL RG GEORGE TK SNYDER DA WATKINS DL DENHAM CA HAYES FA RUBIN AS
Citation: Se. Jones et al., RANDOMIZED DOUBLE-BLIND PROSPECTIVE TRIAL TO EVALUATE THE EFFECTS OF SARGRAMOSTIM VERSUS PLACEBO IN A MODERATE-DOSE FLUOROURACIL, DOXORUBICIN, AND CYCLOPHOSPHAMIDE ADJUVANT CHEMOTHERAPY PROGRAM FOR STAGE-II AND STAGE-III BREAST-CANCER, Journal of clinical oncology, 14(11), 1996, pp. 2976-2983
RANDOMIZED PLACEBO-CONTROLLED TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING-FACTOR SUPPORT FOR DOSE-INTENSIVE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CISPLATIN
Authors: YAU JC NEIDHART JA TRIOZZI P VERMA S NEMUNAITIS J QUICK DP MAYERNIK DG OETTE DH HAYES FA HOLCENBERG J
Citation: Jc. Yau et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING-FACTOR SUPPORT FOR DOSE-INTENSIVE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CISPLATIN, American journal of hematology, 51(4), 1996, pp. 289-295
CYTOKINES AS THERAPY FOR FUNGAL-INFECTIONS IN ACUTE-LEUKEMIA
Authors: ROWE JM HAYES FA ANDERSEN JW WIERNIK PH
Citation: Jm. Rowe et al., CYTOKINES AS THERAPY FOR FUNGAL-INFECTIONS IN ACUTE-LEUKEMIA, Experimental hematology, 24(9), 1996, pp. 536-536
CONVENTIONAL VERSUS MODIFIED MORPHOLOGIC CRITERIA FOR GANGLIONEUROBLASTOMA - A REVIEW OF CASES FROM THE PEDIATRIC-ONCOLOGY-GROUP
Authors: JOSHI VV CANTOR AB ALTSHULER G COHEN LJ LARKIN EW SHUSTER JJ RAO PV HOLBROOK CT HAYES FA CASTLEBERRY RP
Citation: Vv. Joshi et al., CONVENTIONAL VERSUS MODIFIED MORPHOLOGIC CRITERIA FOR GANGLIONEUROBLASTOMA - A REVIEW OF CASES FROM THE PEDIATRIC-ONCOLOGY-GROUP, Archives of pathology and laboratory medicine, 120(9), 1996, pp. 859-865
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS INFECTION PROPHYLAXIS IN HIGH-RISK ONCOLOGIC SURGERY
Authors: MEROPOL NJ PETRELLI NJ LIPMAN BJ RODRIGUEZBIGAS M HICKS W DOUGLASS HO SMITH JL RASEY M BLUMENSON LE VAICKUS L HAYES FA AGOSTI JM
Citation: Nj. Meropol et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS INFECTION PROPHYLAXIS IN HIGH-RISK ONCOLOGIC SURGERY, The American journal of surgery, 172(3), 1996, pp. 299-302
RESULTS OF PEDIATRIC-ONCOLOGY-GROUP PROTOCOL-8104 FOR INFANTS WITH STAGES-D AND STAGE-DS NEUROBLASTOMA
Authors: STROTHER D SHUSTER JJ MCWILLIAMS N NITSCHKE R SMITH EI JOSHI VJ KUN L HAYES FA CASTLEBERRY R
Citation: D. Strother et al., RESULTS OF PEDIATRIC-ONCOLOGY-GROUP PROTOCOL-8104 FOR INFANTS WITH STAGES-D AND STAGE-DS NEUROBLASTOMA, Journal of pediatric hematology/oncology, 17(3), 1995, pp. 254-259
PHASE-III RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RHGM-CSF FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: NEMUNAITIS J ROSENFELD CS ASH R FREEDMAN MH DEEG HJ APPELBAUM F SINGER JW FLOMENBERG N DALTON W ELFENBEIN GJ RIFKIN R RUBIN A AGOSTI J HAYES FA HOLCENBERG J SHADDUCK RK
Citation: J. Nemunaitis et al., PHASE-III RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RHGM-CSF FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(6), 1995, pp. 949-954
DOSE-ESCALATION TRIAL OF CYCLOPHOSPHAMIDE WITH SARGRAMOSTIM IN THE TREATMENT OF CENTRAL-NERVOUS-SYSTEM (CNS) NEOPLASMS
Authors: LACHANCE DH OETTE D SCHOLD SC BROWN M KURTZBERG J GRAHAM ML TIEN R FELSBERG G COLVIN OM MOGHRABI A BROWNING I HOCKENBERGER B STEWART E FERRELL L KERBY T DUNCANBROWN M GOLEMBE B FUCHS H FREDERICKS R HAYES FA RUBIN AS BIGNER DD FRIEDMAN HS
Citation: Dh. Lachance et al., DOSE-ESCALATION TRIAL OF CYCLOPHOSPHAMIDE WITH SARGRAMOSTIM IN THE TREATMENT OF CENTRAL-NERVOUS-SYSTEM (CNS) NEOPLASMS, Medical and pediatric oncology, 24(4), 1995, pp. 241-247
CYCLOPHOSPHAMIDE DOXORUBICIN VS CISPLATIN TENIPOSIDE IN THE TREATMENTOF CHILDREN OLDER THAN 12 MONTHS OF AGE WITH DISSEMINATED NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP RANDOMIZED PHASE-II STUDY
Authors: MCWILLIAMS NB HAYES FA GREEN AA SMITH EI NITSCHKE R ALTSHULER GA SHUSTER JJ CASTLEBERRY RP VIETTI TJ
Citation: Nb. Mcwilliams et al., CYCLOPHOSPHAMIDE DOXORUBICIN VS CISPLATIN TENIPOSIDE IN THE TREATMENTOF CHILDREN OLDER THAN 12 MONTHS OF AGE WITH DISSEMINATED NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP RANDOMIZED PHASE-II STUDY, Medical and pediatric oncology, 24(3), 1995, pp. 176-180
A RANDOMIZED PLACEBO-CONTROLLED PHASE-III STUDY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN ADULT PATIENTS (GREATER-THAN-55 TO 70 YEARS OF AGE) WITH ACUTE MYELOGENOUS LEUKEMIA - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (E1490)
Authors: ROWE JM ANDERSEN JW MAZZA JJ BENNETT JM PAIETTA E HAYES FA OETTE D CASSILETH PA STADTMAUER EA WIERNIK PH
Citation: Jm. Rowe et al., A RANDOMIZED PLACEBO-CONTROLLED PHASE-III STUDY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN ADULT PATIENTS (GREATER-THAN-55 TO 70 YEARS OF AGE) WITH ACUTE MYELOGENOUS LEUKEMIA - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (E1490), Blood, 86(2), 1995, pp. 457-462
PRIMING WITH GM-CSF PRIOR TO HIGH-DOSE CEP CHEMOTHERAPY
Authors: RIVKIN SE HAYES FA FAGNAN L OIEN T KLEMOLAPHILLIPS R
Citation: Se. Rivkin et al., PRIMING WITH GM-CSF PRIOR TO HIGH-DOSE CEP CHEMOTHERAPY, Blood, 86(10), 1995, pp. 3951-3951
CHEST-WALL RESECTION FOR EWINGS-SARCOMA OF THE RIB - AN UNNECESSARY PROCEDURE
Authors: RAO BN HAYES FA THOMPSON EI KUMAR APM FLEMING ID GREEN AA AUSTIN BA PATE JW HUSTU HO
Citation: Bn. Rao et al., CHEST-WALL RESECTION FOR EWINGS-SARCOMA OF THE RIB - AN UNNECESSARY PROCEDURE, The Annals of thoracic surgery, 60(5), 1995, pp. 1454-1455
PHASE-II INVESTIGATIONAL WINDOW USING CARBOPLATIN, IPROPLATIN, IFOSFAMIDE, AND EPIRUBICIN IN CHILDREN WITH UNTREATED DISSEMINATED NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: CASTLEBERRY RP CANTOR AB GREEN AA JOSHI V BERKOW RL BUCHANAN GR LEVENTHAL B MAHONEY DH SMITH EI HAYES FA
Citation: Rp. Castleberry et al., PHASE-II INVESTIGATIONAL WINDOW USING CARBOPLATIN, IPROPLATIN, IFOSFAMIDE, AND EPIRUBICIN IN CHILDREN WITH UNTREATED DISSEMINATED NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(8), 1994, pp. 1616-1620
TREATMENT OF ELDERLY PATIENTS WITH INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - A TRIAL OF THIOTEPA, NOVANTRONE(R) (MITOXANTRONE), ONCOVIN AND PREDNISONE (T-NOP)
Authors: LICHTMAN SM FUSCO D KOLITZ J ALLEN SL VINCIGUERRA V BUDMAN DR SCHULMAN P ZHUKOVSKY D HOFFMAN M MITTLEMAN A HAYES FA
Citation: Sm. Lichtman et al., TREATMENT OF ELDERLY PATIENTS WITH INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - A TRIAL OF THIOTEPA, NOVANTRONE(R) (MITOXANTRONE), ONCOVIN AND PREDNISONE (T-NOP), Blood, 84(10), 1994, pp. 10000164-10000164
SYSTEMATIZATION OF PRIMARY HISTOPATHOLOGIC AND FINE-NEEDLE ASPIRATIONCYTOLOGIC FEATURES AND DESCRIPTION OF UNUSUAL HISTOPATHOLOGIC FEATURES OF NEUROBLASTIC TUMORS - A REPORT FROM THE PEDIATRIC ONCOLOGY GROUP
Authors: JOSHI VV SILVERMAN JF ALTSHULER G CANTOR AB LARKIN EW NEILL JSA NORRIS HT SHUSTER JJ HOLBROOK CT HAYES FA SMITH EI CASTLEBERRY RP
Citation: Vv. Joshi et al., SYSTEMATIZATION OF PRIMARY HISTOPATHOLOGIC AND FINE-NEEDLE ASPIRATIONCYTOLOGIC FEATURES AND DESCRIPTION OF UNUSUAL HISTOPATHOLOGIC FEATURES OF NEUROBLASTIC TUMORS - A REPORT FROM THE PEDIATRIC ONCOLOGY GROUP, Human pathology, 24(5), 1993, pp. 493-504
CORRELATION BETWEEN MORPHOLOGIC AND OTHER PROGNOSTIC MARKERS OF NEUROBLASTOMA - A STUDY OF HISTOLOGIC GRADE, DNA INDEX, N-MYC GENE COPY NUMBER, AND LACTIC-DEHYDROGENASE IN PATIENTS IN THE PEDIATRIC ONCOLOGY GROUP
Authors: JOSHI VV CANTOR AB BRODEUR GM LOOK AT SHUSTER JJ ALTSHULER G LARKIN EW HOLBROOK CT SILVERMAN JF NORRIS HT HAYES FA SMITH EI CASTLEBERRY RP
Citation: Vv. Joshi et al., CORRELATION BETWEEN MORPHOLOGIC AND OTHER PROGNOSTIC MARKERS OF NEUROBLASTOMA - A STUDY OF HISTOLOGIC GRADE, DNA INDEX, N-MYC GENE COPY NUMBER, AND LACTIC-DEHYDROGENASE IN PATIENTS IN THE PEDIATRIC ONCOLOGY GROUP, Cancer, 71(10), 1993, pp. 3173-3181
PHASE-III DOUBLE-BLIND TRIAL OF RHGM-CSF (SARGRAMOSTIN) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT (BMT)
Authors: NEMUNAITIS J ROSENFELD C ASH R FLOMENBERG N FRIEDMAN M DEEG J APPELBAUM F SINGER JW DALTON W ELFENBEIN G RIFKIN R RUBIN A AGOSTI J HAYES FA SHADDUCK RK
Citation: J. Nemunaitis et al., PHASE-III DOUBLE-BLIND TRIAL OF RHGM-CSF (SARGRAMOSTIN) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT (BMT), Blood, 82(10), 1993, pp. 10000286-10000286
RECOMMENDATIONS FOR MODIFICATION OF TERMINOLOGY OF NEUROBLASTIC TUMORS AND PROGNOSTIC-SIGNIFICANCE OF SHIMADA CLASSIFICATION - A CLINICOPATHOLOGICAL STUDY OF 213 CASES FROM THE PEDIATRIC ONCOLOGY GROUP
Authors: JOSHI VV CANTOR AB ALTSHULER G LARKIN EW NEILL JSA SHUSTER JJ HOLBROOK CT HAYES FA CASTLEBERRY RP
Citation: Vv. Joshi et al., RECOMMENDATIONS FOR MODIFICATION OF TERMINOLOGY OF NEUROBLASTIC TUMORS AND PROGNOSTIC-SIGNIFICANCE OF SHIMADA CLASSIFICATION - A CLINICOPATHOLOGICAL STUDY OF 213 CASES FROM THE PEDIATRIC ONCOLOGY GROUP, Cancer, 69(8), 1992, pp. 2183-2196
AGE-LINKED PROGNOSTIC CATEGORIZATION BASED ON A NEW HISTOLOGIC GRADING SYSTEM OF NEUROBLASTOMAS - A CLINICOPATHOLOGICAL STUDY OF 211 CASES FROM THE PEDIATRIC-ONCOLOGY-GROUP
Authors: JOSHI VV CANTOR AB ALTSHULER G LARKIN EW NEILL JSA SHUSTER JJ HOLBROOK CT HAYES FA NITSCHKE R DUNCAN MH SHOCHAT SJ TALBERT J SMITH EI CASTLEBERRY RP
Citation: Vv. Joshi et al., AGE-LINKED PROGNOSTIC CATEGORIZATION BASED ON A NEW HISTOLOGIC GRADING SYSTEM OF NEUROBLASTOMAS - A CLINICOPATHOLOGICAL STUDY OF 211 CASES FROM THE PEDIATRIC-ONCOLOGY-GROUP, Cancer, 69(8), 1992, pp. 2197-2211
Risultati: 1-24 |